• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sensitive methods for evaluation of antibodies for host cell protein analysis and screening of impurities in a vaccine process

tetano

Editor, Senior Moderator
Vaccine. 2014 Mar 10. pii: S0264-410X(14)00205-9. doi: 10.1016/j.vaccine.2014.02.032. [Epub ahead of print]
Sensitive methods for evaluation of antibodies for host cell protein analysis and screening of impurities in a vaccine process.
Lundstr?m CS1, Mattsson A1, L?vgren K2, Eriksson A1, Sundberg AL1, Lundgren M1, Nilsson CE3.
Author information
Abstract
BACKGROUND:

Host cell proteins (HCP) should be carefully monitored in vaccine production. To achieve a reliable HCP estimation, a mixture of polyclonal antibodies (pAbs) with broad affinity would be of preference. Sensitive evaluations of the pAbs are therefore of value.
METHODS:

Column purification of specific HCPs with affinity to the anti-HCP pAbs was compared with Western blotting of the anti-HCP pAbs binding to filter bound total lysate. The anti-HCP pAbs were used in an HCP quantification analysis using surface plasmon resonance (SPR). Host cell derived impurities from an influenza vaccine process were analyzed using 2-D DIGE analysis.
RESULTS:

The Western blotting showed a similar HCP binding pattern of anti-HCP pAbs from immunizations using two adjuvants: CFA/IFA and AbISCO?. From the column purification of HCPs, total proteins detectable were similar for all anti-HCP pAbs; however the immune response pattern differed significantly for the anti-HCP pAbs from the AbISCO? immunization. In the SPR HCP quantification assay the standard curve ranged from 0.3 to 40μg/ml. The advantage of SPR compared with ELISA was the decreased hands on time and that the sample number was not limiting. The 2-D DIGE showed that most of the HCPs were removed at the clarification and virus capture step.
DISCUSSION:

Column purification of HCPs with affinity to the anti-HCP pAbs increased the sensitivity of affinity analysis compared with Western blotting and opened the possibility of further analysis. The anti-HCP pAbs did not interact with proteins in the virus; simplifying analysis of process samples using SPR. 2-D DIGE analysis gave a direct study of the impurity profile with the advantage of independence from antibody performance.

Copyright ? 2014 Elsevier Ltd. All rights reserved.
KEYWORDS:

2-D DIGE, Adjuvant, Biacore, Host cell protein, Influenza virus, SPR

PMID:
24631079
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24631079
 
Back
Top Bottom